Healthcare -
Biotechnology - NASDAQ - US
$ 6.42
1.42 %
$ 570 M
Market Cap
-2.73
P/E
VERV - TOTAL CURRENT ASSETS
Total Current Assets VERV - Verve Therapeutics, Inc.
638 M
LAST VALUE
31.82%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR